Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne Claeys

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Research|March 15, 2023
Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-LetterArne Claeys, Jimmy Van den Eynden
Communications Medicine|September 30, 2024
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanomaArne Claeys, Jimmy Van den Eynden
Plos Genetics|February 8, 2021
Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signalsArne Claeys, Tom Luijts, Kathleen Marchal, et al.
BMC Genomics|May 10, 2023
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS dataArne Claeys, Peter Merseburger, Jasper Staut, et al.
NAR Cancer|January 12, 2024
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEANJonatan L Gabre, Peter Merseburger, Arne Claeys, et al.
Scientific Reports|June 21, 2022
A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissuesTom Luijts, Kerryn Elliott, Joachim Tetteh Siaw, et al.
Nature Communications|November 25, 2021
ATR inhibition enables complete tumour regression in ALK-driven NB mouse modelsJoanna Szydzik, Dan E Lind, Badrul Arefin, et al.
The Journal of Pathology|August 8, 2025
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactionsJoachim T Siaw, Peter Merseburger, Marcus Borenäs, et al.
Iscience|April 6, 2026
RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cellsJoachim Tetteh Siaw, Arne Claeys, Wei-Yun Lai, et al.
The British Journal of Surgery|April 24, 2024
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancerJesse Demuytere, Charlotte Carlier, Tom Van Helden, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Research|March 15, 2023
Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-LetterArne Claeys, Jimmy Van den Eynden
Communications Medicine|September 30, 2024
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanomaArne Claeys, Jimmy Van den Eynden
Plos Genetics|February 8, 2021
Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signalsArne Claeys, Tom Luijts, Kathleen Marchal, et al.
BMC Genomics|May 10, 2023
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS dataArne Claeys, Peter Merseburger, Jasper Staut, et al.
NAR Cancer|January 12, 2024
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEANJonatan L Gabre, Peter Merseburger, Arne Claeys, et al.
Scientific Reports|June 21, 2022
A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissuesTom Luijts, Kerryn Elliott, Joachim Tetteh Siaw, et al.
Nature Communications|November 25, 2021
ATR inhibition enables complete tumour regression in ALK-driven NB mouse modelsJoanna Szydzik, Dan E Lind, Badrul Arefin, et al.
The Journal of Pathology|August 8, 2025
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactionsJoachim T Siaw, Peter Merseburger, Marcus Borenäs, et al.
Iscience|April 6, 2026
RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cellsJoachim Tetteh Siaw, Arne Claeys, Wei-Yun Lai, et al.
The British Journal of Surgery|April 24, 2024
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancerJesse Demuytere, Charlotte Carlier, Tom Van Helden, et al.
Pageof 2